EUVIMEDEUVIMED entdecken
Crossref

The potential impact of radiation-synthesized chitosan coated titanium dioxide nanoparticles on hepatocellular carcinoma: Modulation of autophagy via AMPK, mTOR, and ULK-1 pathways in a rat model

Omnia Ahmed Mohamed, Sawsan Mohamed Elsonbaty, Eman Ibrahim Kandil, Shaimaa Rihan, Nermeen Mohamed Elbakary

Bioorganic Chemistry · 2026-11 · 184 · 110672

DOI: 10.1016/j.bioorg.2026.110672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Omnia Ahmed Mohamed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science - Ain Shams University, Cairo, Egypt. Electronic address: omniaahmed20@yahoo.com. Hauptthemen laut MEDLINE: Titanium, Chitosan, Carcinoma, Hepatocellular, Nanoparticles. Die Arbeit nennt 91 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liver cancer remains a major clinical challenge due to limited treatment options and significant treatment-related toxicity. Nanotechnology offers new avenues to enhance therapeutic efficacy and tissue specificity while reducing systemic adverse effects. This study emphasizes the protective effect of chitosan-coated titanium dioxide nanoparticles (CS-TiO2 NPs) against hepatocellular carcinoma (HCC) induced in rats. AIM: To evaluate whether CS-TiO2 NPs can mitigate DEN-induced hepatocellular carcinoma in rats by modulating autophagy via AMPK, mTOR, and ULK-1 pathways, restoring redox balance, and suppressing tumor-promoting signaling. METHODS AND EXPERIMENTAL DESIGN: Adult rats were allocated to six groups, including normal controls, DEN-induced cancer controls, chitosan coated titanium dioxide nanoparticles controls, 5-Fluorouracil controls, CS-TiO2 NPs plus DEN treatment and 5-FU plus DEN. Biochemical assays assessed hepatic injury (ALT, AST), renal function (urea, creatinine), oxidative stress (MDA, GSH), and tumor markers (β-catenin, NOTCH1, AFP). Autophagy-related signaling (AMPK, ULK-1, mTOR), apoptosis was evaluated by measuring Annexin V and measuring of Cytochrome P450 2E1 (CYP2E1) for detecting drug metabolism, toxicology and overall biological response, complemented by histopathology to characterize liver architecture and tumor-associated changes. KEY FINDINGS: CS-TiO2 NPs treatment significantly reduced DEN-induced hepatic injury, evidenced by significant decrease in ALT and in AST relative to cancer controls, and substantially improved renal function (urea and creatinine reduction). Redox balance was favorably shifted, with marked reductions in MDA and restoration of GSH, especially with γ-irradiation-synthesized CS-TiO2 NPs. Oncogenic signaling was attenuated, with a meliorative decrease in β-catenin and NOTCH1 in the CS-TiO2 NPs treated group compared with cancer controls. Autophagy-related markers indicated restoration of autophagic activity: DEN suppressed AMPK and ULK-1 and elevated mTOR, whereas CS-TiO2 NPs reversed these alterations, suggesting reactivation of autophagy initiation signaling network. Apoptosis assessments revealed increased pro-death signaling in treated groups, aligning with enhanced tumor cell clearance. Histopathological evaluation demonstrated improved hepatic architecture and reduced tumor-associated pathology with CS-TiO2 NPs treatment. CONCLUSION: CS-TiO2 nanoparticles confer a dual protective effect in DEN-induced rat HCC by directly modulating tumor-promoting signaling and by re-programming autophagy and redox homeostasis to favor tumor suppression and hepatic integrity. The observed downregulation of β-catenin and NOTCH1, together with restored AMPK-ULK-1-mTOR signaling and improved histology, supports the potential of CS-TiO2 NPs as multifunctional nanotherapeutics for liver cancer. Further work should elucidate precise autophagic flux dynamics, biodistribution, and long-term safety to facilitate clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TitaniumChitosanCarcinoma, HepatocellularNanoparticlesAntineoplastic AgentsLiver NeoplasmsAnimalsRatsTOR Serine-Threonine KinasesAutophagyMaleAutophagy-Related Protein-1 HomologAMP-Activated Protein KinasesSignal TransductionRats, Sprague-DawleyDisease Models, AnimalDose-Response Relationship, Drug

Stichwörter der Autor:innen

AFPAMPKAnnexin VCS-TiO(2) NPsHCCNOTCH1ULK-1mTORβ-catenin

Substanzen

Titaniumtitanium dioxideTOR Serine-Threonine KinasesChitosanAutophagy-Related Protein-1 HomologAMP-Activated Protein KinasesULK1 protein, ratAntineoplastic AgentsmTOR protein, rat

Autor:innen und Institutionen

  • Faculty of Science - Ain Shams University, Cairo, Egypt. Electronic address: omniaahmed20@yahoo.com.
  • Radiation microbiology Department- National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
  • Faculty of Science - Ain Shams University, Cairo, Egypt.
  • Radiation Biology Department- National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt. Electronic address: nermeen_ahmed11@yahoo.com.

Zitieren

APA

Mohamed, O. A., Elsonbaty, S. M., Kandil, E. I., Rihan, S., & Elbakary, N. M. (2026). The potential impact of radiation-synthesized chitosan coated titanium dioxide nanoparticles on hepatocellular carcinoma: Modulation of autophagy via AMPK, mTOR, and ULK-1 pathways in a rat model. Bioorganic Chemistry, 184, 110672. https://doi.org/10.1016/j.bioorg.2026.110672

Vancouver

Mohamed OA, Elsonbaty SM, Kandil EI, Rihan S, Elbakary NM. The potential impact of radiation-synthesized chitosan coated titanium dioxide nanoparticles on hepatocellular carcinoma: Modulation of autophagy via AMPK, mTOR, and ULK-1 pathways in a rat model. Bioorganic Chemistry. 2026;184:110672. doi:10.1016/j.bioorg.2026.110672

BibTeX
@article{Mohamed2026,
  author = {Mohamed, Omnia Ahmed and Elsonbaty, Sawsan Mohamed and Kandil, Eman Ibrahim and Rihan, Shaimaa and Elbakary, Nermeen Mohamed},
  title = {The potential impact of radiation-synthesized chitosan coated titanium dioxide nanoparticles on hepatocellular carcinoma: Modulation of autophagy via AMPK, mTOR, and ULK-1 pathways in a rat model},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {184},
  pages = {110672},
  doi = {10.1016/j.bioorg.2026.110672}
}
Kostenlos starten →